EBV-Negative Monomorphic B-Cell Posttransplant Lymphoproliferative Disorder with Marked Morphologic Pleomorphism and Pathogenic Mutations in ASXL1, BCOR, CDKN2A, NF1, and TP53

<div>IGH PCR analysis of the small bowel tumor. IGH PCR analysis using primers for framework 2 (FR2) region identified two clonal peaks at approximately 163.85 bp and 243.99 bp (a). Primers targeting framework 3 (FR3) region identified a 78 bp peak (b).</div>

Case Reports in Hematology

fig4

Figure 4

Figure 4: EBV-Negative Monomorphic B-Cell Posttransplant Lymphoproliferative Disorder with Marked Morphologic Pleomorphism and Pathogenic Mutations in ASXL1, BCOR, CDKN2A, NF1, and TP53

Figure 4 | EBV-Negative Monomorphic B-Cell Posttransplant Lymphoproliferative Disorder with Marked Morphologic Pleomorphism and Pathogenic Mutations in ASXL1, BCOR, CDKN2A, NF1, and TP53 